Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Assessment of Clinical Features and Biomarkers to Identify Patients With Advanced or Metastatic Breast Cancer for Marker Driven Trials in Humans (CATCH)

NCT05652569 is registered in ClinicalTrials.gov with German Cancer Research Center as lead sponsor.

NCT NCT05652569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05652569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Assessment of Clinical Features and Biomarkers to Identify Patients With Advanced or Metastatic Breast Cancer for Marker Driven Trials in Humans (CATCH)
Lead sponsor
German Cancer Research Center
Phase
Observational
Overall status
Recruiting
Start date
June 12, 2017
Completion date
December 31, 2030
Enrollment
5,000 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer